Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Arrowhead concludes dosing in Phase I ARO-AAT trial

Photomicrograph of a liver biopsy from a patient with alpha-1 antitrypsin deficiency. Credit: Jerad M Gardner.



Go Top